{
    "2020-10-14": [
        [
            {
                "time": "",
                "original_text": "流感、肺炎疫苗迎来“高光”时刻，3季度疫苗签发数据“专治各种不服”",
                "features": {
                    "keywords": [
                        "流感",
                        "肺炎疫苗",
                        "签发数据",
                        "高光时刻"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "1只个股尾盘净流入资金超亿元",
                "features": {
                    "keywords": [
                        "个股",
                        "尾盘",
                        "净流入",
                        "资金"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "医药行业2020年四季度投资策略：业绩验证化解估值压力",
                "features": {
                    "keywords": [
                        "医药行业",
                        "投资策略",
                        "业绩验证",
                        "估值压力"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "【中原医药】医药行业专题研究：换个角度看待医药：从财务指标和估值来挖掘医药领域的投资机会",
                "features": {
                    "keywords": [
                        "中原医药",
                        "专题研究",
                        "财务指标",
                        "估值",
                        "投资机会"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "【山证医药】2020年8月血制品批签发数据跟踪：1-8月整体批签发维持稳步增长，多数品种实现较高增速",
                "features": {
                    "keywords": [
                        "山证医药",
                        "血制品",
                        "批签发数据",
                        "稳步增长",
                        "较高增速"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "券商晨会观点速递",
                "features": {
                    "keywords": [
                        "券商晨会",
                        "观点速递"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "天风证券：三季度重点疫苗品种批签发整体同比表现强劲 推荐沃森生物等",
                "features": {
                    "keywords": [
                        "天风证券",
                        "疫苗",
                        "批签发",
                        "同比表现强劲",
                        "沃森生物"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            }
        ]
    ]
}